AMSBIO is a leading supplier of cryopreserved primary human cells for research from multiple organs including the lung, liver, intestine, and kidney. Drawing upon well-established partnerships with respected organ procurement organizations, AMSBIO has access to samples that allow direct isolation of a wide range of cells that retain their original morphological and functional characteristics. Every batch of cells is validated for cell viability, morphology, plating efficiency and cell marker data. Cells are cultured for 5-7 days before being released and delivered with donor demographics…

• Ready built, affordable, wet laboratory and write-up space situated in Ware - an established life science location between London and Cambridge. • Riverlabs 1: 113,297 sq ft (GIA) available for fit out from January 2023. • Riverlabs 2: 219,900 sq ft (GIA) available for fit out in May 2023. • Situated on the River Lea with direct river access, Riverlabs enjoys unparalleled amenity providing the perfect environment for life science companies to thrive. London, UK, Tuesday 15th November 2022: European and US real estate asset manager and investor, Global Mutual, founded in 2008, today confirms…

View the latest updates on One Nucleus careers conferece, Building Life Science Adventures 2023. Join us for the annual Building Life Science Adventures (BLSA) careers conference on 28-29 March 2023. Creating careers, not just jobs, is a two-way process between those seeking to build their adventures in science and those seeking to build the best teams. This One Nucleus careers conference is free to attend and a chance to fill knowledge gaps, debate best practice and connect to enable success. Sign up now!

• New logo and website created to reflect Leaf’s progression • Better user experience with in-depth information on services and R&D Norwich, UK - 24 January 2023 Leaf Expression Systems (Leaf), a plant-based contract research and product development company working to serve the global life sciences (human and animal health), agribiotech, food and consumer care industries has launched a new logo and website, leafexpressionsystems.com. The logo and website reflect the progression Leaf has made from an academic spin-out to an established commercial organisation with a clear mission - to use…

The EU Commission launched the process regarding the adoption of an adequacy decision for EU-U.S. How the #adequacydecision for United States will improve #datatransfers between EU and U.S.? An adequacy decision is a formal decision of the European Commission recognising that a country outside the EU provides an essentially equivalent level of data protection to that within the European Economic Area (EEA). There is no time limitation, however, the European Commission continuously monitors developments in countries and international organisations that could affect its decision. The adequacy…

Click here to view the January 2023 edition of The Meeting Place.

  Monday 23rd January 2022: Creative Places is delighted to announce the appointment of Liam Nicholls to the position of CEO. Liam takes over from Jonathan Burroughs, who will remain fully involved in the business, focusing on client work. Having joined Creative Places seven years ago, Liam’s expertise and tenacity has proven invaluable to the commercial property experts, which utilises its specialist, sector specific knowledge to help clients plan, create, manage and invest in collaborative places for people involved with research, R&D and innovation. Specifically…

o2h discovery, a preclinical Contract Research Organization which has an integrated drug discovery platform, is pleased to announce the second edition of the o2h kickstarter competition exclusively aimed towards supporting Australian early stage biotech companies. After the overwhelming response to the first competition, we are back with another edition to specifically support early stage Aus Biotech in their drug discovery programmes. Aus Biotech has a globally competitive biotech ecosystem which has impact significantly higher than its size compared to the overall global Biotech sector. We…

New company created to enable commercial manufacture of new cell and gene therapies Cellular Origins’ proprietary technology will address current barriers associated with cost-effective and efficient manufacture of cell and gene therapies at scale Cambridge, UK, 17 January 2023: TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient manufacture of cell and gene therapies. Cellular Origins’ proprietary…

Expansion of five-year collaboration broadens established Organ-on-a-chip research demonstrating advanced performance of the PhysioMimix MPS New research project to investigate the use of multi-organ MPS to improve estimation of human drug bioavailability in comparison to existing animal models Cambridge, UK, 17th January 2023: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that the U.S. Food and Drug Administration (FDA) and CN Bio have expanded their collaboration for the second time,…